Delivery Order SPE2DB25D3201-SPE2DB25FNTJC

Award Date 5/22/25
Potential Completion Date 6/13/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $2,652.57 and a completion date of June 13, 2025. The contract is a Firm Fixed Price type, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. The award has a ceiling value of $31,830.84 and a completion date of May 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $7,957.71. The contract is a firm fixed-price delivery order, with a period of performance through June 3, 2025. The award is not associated with a set-aside designation, indicating open...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,830.84, is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a firm fixed price pricing type and runs through May 5, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,915.42, is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a performance period that extends through May 29, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $21,220.56. The contract has an ultimate completion date of March 7, 2025 and was awarded on February 13, 2025. This appears to be a delivery order contract with a firm fixed price pricing type. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IMFINZI 500 MG/10 ML VIAL 10ML. The contract has a ceiling value of $23,873.13 and a performance period extending through June 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a ceiling value of $23,873.13 and is a firm fixed-price delivery order that does not utilize any set-aside designation. The contract has an ultimate completion date of May 29, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $26,525.70. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has a completion date of June 20, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $31,830.84. The contract is a Delivery Order awarded on May 13, 2025, with a completion date of June 4, 2025. It is a Firm Fixed Price contract, with no set-aside designation. This award is associated with a...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNTJC
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a firm fixed price ceiling value of $2,652.57. The award date is May 22, 2025, and the ultimate completion date is June 13, 2025. This is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/21/25, 9:56 AM